We examined the outcome and the complications of endoscopic balloon dilatation (EBD) of ileocaecal and colonic strictures due to Crohn’s disease.
We examined 237 dilatation procedures in 77 patients with symptomatic ileocaecal and colonic stenosis regarding outcome, individual perforation risk, the need for further interventions, and other complications within a 10 years observation period.
In 50 of 77 patients (64.9 %), endoscopic dilatation procedures were successful within a median follow-up period of 24 months (25th and 75th percentile 10–38.5 months). Thirty five patients (45.5 %) were successfully dilated with only one endoscopic procedure, while the remaining patients required two or more EBDs. Albeit the EBD, 27 patients of the whole cohort (35.1 %) underwent surgical repair of the stenosis in due course. Overall complication rate was 7.6 %, with postdilatation bleeding in 1.7 % and abdominal pain longer than 24 h in 4.2 %. Perforation occurred in 4 of 77 patients (5.2 %), resulting in a perforation rate of 1.7 % per intervention, or, more importantly, for the individual patient in a long-term perforation rate of 5.2 % per patient, respectively.
Endoscopic balloon dilatation (EBD) is a safe and effective approach to ileocaecal and colonic stenosis in approximately 65 % of Crohn’s disease patients. Even in case of recurrence, further endoscopic treatments can be undertaken. The perforation rate depending on the number of interventions is low, but for the individual patient a cumulative per patient perforation risk of 5.2 % in the long-term should be considered during patient information and decisions for or against surgical interventions.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
McKaig BC, Hughes K, Tighe PJ, Mahida YR (2002) Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol 282:C172–C182
Beddy D, Mulsow J, Watson RW, Fitzpatrick JM, O’connell PR (2006) Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn’s disease. Br J Surg 93:1290–1296
Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8:244–250
Gasche C, Schölmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ (2002) A simple classification of Crohn’s disease: report of Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15
Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I (2007) IBSEN Study Group Clinical course in Crohn’s disease: results of a Norwegian population based ten-year follow-up study. Clin Gastroenterol Hepatol 5:1430–1438
Oberhuber G, Stangl PC, Vogelsang H, Schober E, Herbst F, Gasche C (2000) Significant association of strictures and internal fistula formation in Crohn’s disease. Virchows Arch 437:293–297
Vrabie R, Irwin GL, Friedel D (2012) Endoscopic management of inflammatory bowel disease strictures. World J Gastrointest Endoscopy 16(4(11)):500–505
Krupnick AS, Morris JB (2000) The long-term results of resection and multiple resections in Crohn’s disease. Semin Gastrointest Dis 11:41–51
Hahn M, Raithel M, Hagel A, Biermann T, Manger B (2012) Chronic calcium pyrophosphate crystal inflammatory arthritis induced by extreme hypomagnesemia in short bowel syndrome. BMC Gastroenterology 12:129–132
Legnani PE, Kornbluth A (2002) Therapeutic options in the management of strictures in Crohn’s disease. Gastrointest Endosc Clin N Am 12:589–603
Tichansky D, Cagir B, Yoo E, Marcus SM, Fry RD (2000) Strictureplasty for Crohn’s disease: meta-analysis. Dis Colon Rectum 43:911–919
Yamamoto T, Fazio VW, Tekkis PP (2007) Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum 50:1968–1986
Blomberg B, Rolny P, Jarnerot G (1991) Endoscopic treatment of anastomotic strictures in Crohn’s disease. Endoscopy 23:195–198
Couckuyt H, Gevers AM, Coremans G, Hiele M, Rutgeerts P (1995) Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective long term analysis. Gut 36:577–580
Hassan C, Zullo A, De Francesco V, Ierardi E, Giustini M, Pitidis A, Taggi F, Winn S, Morini S (2007) Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther 26(11–12):1457–1464
Hoffmann JC, Heller F, Faiss S, von Lampe B, Kroesen AJ, Wahnschaffe U, Schulzke JD, Zeitz M, Bojarski C (2008) Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness. Int J Colorectal Dis 23(7):689–696
Thomas-Gibson S, Brooker JC, Hayward CM, Shah SG, Williams CB, Saunders BP (2003) Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 15:485–488
Morini S, Hassan C, Lorenzetti R, Zullo A, Cerro P, Winn S, Giustini M, Taggi F (2003) Long-term outcome of endoscopic pneumatic dilatation in Crohn’s disease. Dig Liver Dis 35:893–897
Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G (1984) Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut 25:665–672
Mueller T, Rieder B, Bechtner G, Pfeiffer A (2010) The response of Crohn’s strictures to endoscopic balloon dilation. Aliment Pharmacol Ther 31(6):634–639
Scimeca D, Mocciaro F, Cottone M, Montalbano LM, D’Amico G, Olivo M, Orlando R, Orlando A (2011) Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn’s disease strictures. Dig Liver Dis 43(2):121–125
Sabate JM, Villarejo J, Bouhnik Y, Allez M, Gornet JM, Vahedi K, Modigliani R, Lémann M (2003) Hydrostatic balloon dilatation of Crohn’s strictures. Aliment Pharmacol Ther 18:409–413
Ferlitsch A, Reinisch W, Puspok A, Dejaco C, Schillinger M, Schöfl R, Pötzi R, Gangl A, Vogelsang H (2006) Safety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease strictures. Endoscopy 38:483–487
Thienpont C, D’Hoore A, Vermeire S, Demedts I, Bisschops R, Coremans G, Rutgeerts P, Van Assche G (2010) Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut 59(3):320–324
Gustavsson A, Magnuson A, Blomberg B, Andersson M, Halfvarson J, Tysk C (2013) Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn’s disease. Aliment Pharmacol Ther 37(4):430–437
Yamamoto T, Keighley MR (2000) Smoking and disease recurrence after operation for Crohn’s disease. Br J Surg 87:398–404
Griffiths AM (2005) Enteral nutrition in the management of Crohn’s disease. JPEN J Parenter Enteral Nutr 29(4 Suppl):S108–S112
Schwab D, Raithel M, Hahn EG (1998) Enteral nutrition in acute Crohn disease. Z Gastroenterol 36(11):983–995
Stienecker K, Gleichmann D, Neumayer U, Glaser HJ, Tonus C (2009) Long-term results of endoscopic balloon dilatation of lower gastrointestinal tract strictures in Crohn’s disease: a prospective study. World J Gastroenterol 15(21):2623–2627
Singh VV, Draganov P, Valentine J (2005) Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn’s disease strictures. J Clin Gastroenterol 39:284–290
Hagel AF, Hahn A, Dauth W, Matzel K, Konturek P, Neurath MF, and Raithel M, have no conflicts of interest or financial ties concerning this study to declare.
For the conduct of this study, no grants or funding were obtained.
About this article
Cite this article
Hagel, A.F., Hahn, A., Dauth, W. et al. Outcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn’s disease. Surg Endosc 28, 2966–2972 (2014). https://doi.org/10.1007/s00464-014-3559-x
- Crohn’s disease
- Endoscopic balloon dilatation
- Colonic stenosis
- Ileocaecal stenosis